Results 31 to 40 of about 125,028 (162)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage

Рациональная фармакотерапия в кардиологии, 2021
Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered for decreasing risk of stroke and systemic embolism ...
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov   +3 more
doaj   +1 more source

How to define the relative contraindications to oral anticoagulant therapy

Monaldi Archives for Chest Disease, 2017
There is currently a lack of consensus on which anticoagulant therapy contraindications should be considered “absolute” and which should be considered “relative”. Guidelines do not clearly identify absolute and relative contraindications to anticoagulant
Roberto F.E. Pedretti
doaj   +1 more source

Anticoagulation therapy for intra-abdominal hypertension in patients with acute pancreatitis

BMC Gastroenterology
Background Intra-abdominal hypertension (IAH) is a common complication in patients with acute pancreatitis (AP) and can lead to multiple organ failure. The efficacy of anticoagulant therapy for IAH in patients with acute pancreatitis is unclear.
Yan Ge, Li Ma, Wenwu Sun, Bing Zhao, Ying Chen, Zhitao Yang, Erzhen Chen, Weisong Jiang, Enqiang Mao, Tongtian Ni   +9 more
doaj   +1 more source

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP

Атеротромбоз, 2017
For patients with atrial fibrillation, long-term oral anticoagulant therapy reduces the risk of ischemic stroke and systemic embolism, while increasing the risk of hemorrhagic complications.
E. S. Kropacheva, E. P. Panchenko
doaj   +1 more source

D-dimer trends predict recurrent stroke in patients with cancer-related hypercoagulability

Cerebrovascular Diseases Extra, 2023
Introduction: In patients with cancer-associated hypercoagulability (CAH)-related stroke, D-dimer trends after anticoagulant therapy may offer a biomarker of treatment efficacy.
Jun Fujinami, Yoshinari Nagakane, Kei Fujikawa, Shohei Murata, Keiko Maezono, Tomoyuki Ohara, Toshiki Mizuno   +6 more
doaj   +1 more source

Knowledge and practicing pattern of patients following oral anticoagulant therapy in a tertiary health-care center

National Journal of Physiology, Pharmacy and Pharmacology
Background: Oral anticoagulant therapy is frequently used for the diagnosis, treatment, and prevention of heart diseases. Oral anticoagulants need to be constantly managed when used long term and outside of a hospital setting since they have a restricted
Fateen Shareef, Mohammed Abdul Wasay, Azha Fatima, Shaik Nagma Shaheen, Sri Akhila P, Arooba Fatima, Mohammed Wajhiuddin Farooqi, Mohammed Mahmood Mohiuddin   +7 more
doaj   +1 more source

Management of patients on anticoagulant therapy undergoing dental extractions: a systematic review

Revista Facultad de Odontología Universidad de Antioquia, 2016
Introduction: the management of patients who have undergone dental surgeries and are on antithrombotic therapy is debatable. The goal of this study was to establish the management of patients on anticoagulant therapy prior to dental extractions. Methods:
Patricio Oliva-Mella, Maria Francisca Ruiz-Gutiérrez   +1 more
doaj   +1 more source

Escaping the catch 22 of lupus anticoagulant testing

RMD Open, 2020
High-risk patients with antiphospholipid syndrome (APS) experience increased risk of thrombosis when treated with direct oral anticoagulant (DOAC) therapy compared with warfarin.
Søren Andreas Just, Pernille Just Vinholt   +1 more
doaj   +1 more source

Anticoagulant Therapy Overview [PDF]

American Society for Clinical Laboratory Science, 2013
1. George A. Fritsma, MS MT (ASCP)[⇑][1] 1. The Fritsma Factor, Your Interactive Hemostasis ResourceSM, Fritsma & Fritsma LLC, Birmingham, AL 1. Address for Correspondence: George A. Fritsma MS MT (ASCP), The Fritsma Factor, Your Interactive Hemostasis ResourceSM, Fritsma & Fritsma LLC, 153 Redwood Drive, Birmingham, AL 35173, 205-655-0687,
openaire   +2 more sources

Warfarin Related Kidney Damage: A Confusing Case of Thrombophlebitis Masquerading as Infection

Journal of Primary Care & Community Health, 2023
Anticoagulant-related nephropathy (ARN) is a rare, newly recognized cause of acute kidney injury and significant but underdiagnosed complication of anticoagulation therapy. ARN occurs in patients taking oral anticoagulant therapy most often warfarin or a
Samuelson Brittanee, Decker Matthew, Scott Hannah, Garrison Gregory   +3 more
doaj   +1 more source